Advertisement Direvo signs second cooperation agreement with Danisco - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Direvo signs second cooperation agreement with Danisco

Direvo Biotech and Genencor division of Danisco have signed their second collaboration agreement.

Under the terms of the agreement, Danisco will obtain worldwide exclusive rights to commercialize the product or products developed under this collaboration. In return, Direvo will receive R&D funding, milestone payments and royalties on future product sales.

Anindya Mukherjee, executive vice president of industrial biotechnology at Direvo, said: “This agreement further validates our technology platform and our business concept of creating high value products for leading companies.”